SCHEMBL5175484

SCHEMBL5175484

C=C1c2ccccc2N(C)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.50
CES1 P23141 1/20 0.50
NR1H3 Q13133 8/20 0.47
NR1H2 P55055 6/20 0.47
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
DRD2 P14416 2/20 0.44
HTR6 P50406 2/20 0.44
MAOA P21397 1/20 0.44
CHRM2 P08172 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
DRD1 P21728 1/20 0.44
SLC6A2 P23975 1/20 0.44
HTR2A P28223 1/20 0.44
SLC6A4 P31645 1/20 0.44
HTR7 P34969 1/20 0.44
ADRA1A P35348 1/20 0.44
HRH1 P35367 1/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13768685 0.91 NR1H3 (0.50) TTRCES1NR1H3NR1H2LMNA
SCHEMBL6000324 0.82 TTR (0.64) TTRCES1NR1H3NR1H2LMNA
SCHEMBL31107472 0.82 TTR (0.64) TTRCES1NR1H3NR1H2LMNA
SCHEMBL2604394 0.81 TTR (0.56) TTRCES1LMNAMAPTDRD2
SCHEMBL30542242 0.79 TTR (0.54) TTRCES1LMNAMAPTDRD2
SCHEMBL3797403 0.79 TTR (0.54) TTRCES1LMNAMAPTDRD2
SCHEMBL11882604 0.77 TTR (0.52) TTRCES1LMNAMAPTDRD2
SCHEMBL19792450 0.76 TTR (0.47) TTRCES1NR1H3NR1H2LMNA
SCHEMBL19932851 0.75 NR1H3 (0.33) TTRCES1NR1H3NR1H2DRD2
SCHEMBL13629815 0.75 NR1H3 (0.38) TTRCES1NR1H3NR1H2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018217538-A1 SYNTHESIS OF SUBSTITUTED ACRIDINES UNIVERSITY OF ST. THOMAS (US) 2018-11-29 WO disclosed
US-9526769-B2 Macrocylic oximyl hepatitis C protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2016-12-27 US disclosed
US-8940688-B2 Fluorinated tripeptide HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-01-27 US disclosed
US-20140349297-A1 FLUORESCENT DYES BASED ON ACRIDINE AND ACRIDINIUM DERIVATIVES ALMAC SCIENCES (SCOTLAND) LIMITED (GB) 2014-11-27 US disclosed
US-20140349297-A1 FLUORESCENT DYES BASED ON ACRIDINE AND ACRIDINIUM DERIVATIVES ALMAC SCIENCES (SCOTLAND) LIMITED (GB) 2014-11-27 US disclosed
WO-2013093481-A1 FLUORESCENT DYES BASED ON ACRIDINE AND ACRIDINIUM DERIVATIVES ALMAC SCIENCES (SCOTLAND) LIMITED (GB) 2013-06-27 WO disclosed
US-8426360-B2 Carbocyclic oxime hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2013-04-23 US disclosed
US-8361958-B2 Oximyl HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2013-01-29 US disclosed
EP-1509601-B1 FLUORESCENT DETECTION OF PEROXIDASE ENZYMES LUMIGEN INC (US) 2012-12-05 EP disclosed
US-8268776-B2 mixture of cytochrome P450 monooxygenase inhibitor and protease inhibitor for anti-hepatitis C viral treatment; including other active drugs as interferon, ribavarin, and adamantine ENANTA PHARMACEUTICALS, INC. (US) 2012-09-18 US disclosed
US-20070026334-A1 Electrophotographic photoreceptor and image forming apparatus including the same SHARP KABUSHIKI KAISHA (JP) 2007-02-01 US disclosed
EP-0984281-B1 A homogeneous assay for determining analyte DADE BEHRING MARBURG GMBH (DE) 2007-01-03 EP disclosed
EP-1418430-A2 A homogeneous assay for determining analyte Dade Behring Marburg GmbH (DE) 2004-05-12 EP disclosed
EP-0984282-B1 Particles having an incorporated composition comprising a chemiluminescent compound DADE BEHRING MARBURG GMBH (DE) 2003-07-30 EP disclosed
US-6406913-B1 ANALYZING A SAMPLE, TREATING WITH ENERGY AND DETECTION A SIGNAL DADE BEHRING MARBURG GMBH (DE) 2002-06-18 US disclosed
EP-0515194-B1 Assay methods utilizing induced luminescence DADE BEHRING MARBURG GMBH (DE) 2001-10-31 EP disclosed
US-6251581-B1 MIXTURE OF SUSPENDABLE PARTICLES, ONE TYPE IS CHEMILUMINESCENT COMPOUND CAPABLE OF REACTING WITH SINGLET OXYGEN, THE OTHER TYPE IS PHOTOSENSITIZER WHICH IS CAPABLE OF ACTIVATING OXYGEN TO ITS SINGLET STATE DADE BEHRING MARBURG GMBH (DE) 2001-06-26 US disclosed
EP-0984282-A2 Particles having an incorporated composition comprising a chemiluminescent compound Dade Behring Marburg GmbH (DE) 2000-03-08 EP disclosed
EP-0984281-A2 A homogeneous assay for determining analyte Dade Behring Marburg GmbH (DE) 2000-03-08 EP disclosed
EP-0515194-A2 Assay methods utilizing induced luminescence BEHRINGWERKE Aktiengesellschaft (DE) 1992-11-25 EP disclosed